MDL | - |
---|---|
Molecular Weight | 432.90 |
Molecular Formula | C20H25ClN6O3 |
SMILES | O=C(O)C1=CC=C(NC2=C3N=CN(C(C)C)C3=NC(N[C@@H](CO)C(C)C)=N2)C=C1Cl |
Purvalanol B (NG 95) is a potent, selective, reversible and ATP-competitive inhibitor CDK , with IC 50 s of 6 nM, 6 nM, 9 nM, 6 nM for cdc2-cyclin B , CDK2-cyclin A , CDK2-cyclin E and CDK5-p35 , respectively. Purvalanol B shows selectivity for CDK over a range of other protein kinases (IC 50 >1000 nM). Purvalanol B inhibits the growth a chloroquine-resistant strain of P. falciparum [1] [1] .
cdc2/cyclin B 6 nM (IC 50 ) |
cdk2/cyclin A 6 nM (IC 50 ) |
CDK2/cyclinE 9 nM (IC 50 ) |
CDK5/p35 6 nM (IC 50 ) |
Purvalanol B binds to P. falciparum casein kinase 1 (CK1) from blood stage cell lysates and inhibits the growth a chloroquine-resistant strain of P. falciparum (FCR-3) with an IC 50 of 7.07 μM [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : ≥ 40 mg/mL ( 92.40 mM )
* "≥" means soluble, but saturation unknown.
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.3100 mL | 11.5500 mL | 23.1000 mL |
5 mM | 0.4620 mL | 2.3100 mL | 4.6200 mL |
10 mM | 0.2310 mL | 1.1550 mL | 2.3100 mL |
Add each solvent one by one: 10% DMSO >> 90% corn oil
Solubility: ≥ 2.5 mg/mL (5.78 mM); Clear solution